LOIM
ICPT

Liberty One Investment Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Liberty One Investment Management’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-329
Closed -$16K – 136
2020
Q2 		$16K Buy
+329
New +$25.4K ﹤0.01% 135

Other funds holding ICPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

Liberty One Investment Management's ICPT Position: Q3 2020 in Review

Liberty One Investment Management sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q3 2020, closing a stake of 329 shares — an estimated $16K sold.

Liberty One Investment Management first reported a position in ICPT in Q2 2020 and held it in 1 quarter. The position peaked at $16K in Q2 2020. 177 funds tracked by Wall St. Rank hold ICPT as of Q3 2020.

  • Liberty One Investment Management reported no remaining Intercept Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
  • Liberty One Investment Management sold 329 Intercept Pharmaceuticals, Inc. shares in Q3 2020, an estimated $16K.
  • Liberty One Investment Management first reported a position in Intercept Pharmaceuticals, Inc. in Q2 2020 and held it in 1 quarter.
  • Liberty One Investment Management's Intercept Pharmaceuticals, Inc. position peaked at $16K in Q2 2020.
  • 177 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q3 2020.

Based on Liberty One Investment Management's 13F filing for Q3 2020, filed 3 Nov 2020.